PUBLISHER: Grand View Research | PRODUCT CODE: 1727996
PUBLISHER: Grand View Research | PRODUCT CODE: 1727996
The global eyelid surgery market size is anticipated to reach USD 10.15 billion by 2030 and is projected to expand at a CAGR of 5.6% during the forecast period, according to a new report by Grand View Research, Inc. The rising eye-related problems influenced by the growing geriatric population is one of the major factors contributing to the market growth. According to the International Society of Aesthetic Plastic Surgery (ISAPS), over 1.7 million eyelid surgeries were performed globally in 2023, marking a substantial 24% increase compared to the preceding year. This demographic trend underscores the rising need for surgical interventions to address age-related conditions such as ptosis and baggy eyelids.
The escalating preference for minimally invasive procedures is a key factor propelling market expansion. The advantages associated with these techniques, including faster recovery periods, enhanced patient comfort, and shorter turnaround times, are anticipated to fuel demand for advanced eyelid surgery techniques throughout the forecast period. Technological advancements in the field, exemplified by the development of innovative methods like Rinsada's eyelid retractor, have further augmented the procedure's appeal by reducing associated risks and improving outcomes.
Recent activities among prominent companies in the market are also contributing to industry growth. Notably, in July 2024, Osheru, a medical device company specializing in innovative skin surgery solutions, announced the successful completion of a funding round that garnered over USD 4.0 million. This investment intended to accelerate the development and commercialization of Ziplyft, a medical device specifically designed to address challenges associated with blepharoplasty, indicating ongoing innovation and investment within the industry.